Pharmafile Logo
Pharmafocus logo
Advanced Search
Xalkori image

Pfizer’s Xalkori impresses in new setting

March 26, 2014
Research and Development, Sales and Marketing NHS, NICE, NSCLC, Pfizer, Xalkori, lung cancer

Pfizer’s lung cancer treatment Xalkori has proven better at treating patients in a first-line setting when compared to chemotherapy. This …

News
ernesto_quinteros

J&J appoints chief design officer

March 26, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ernesto Quinteros, J&J, JJ, belkin, design

Johnson & Johnson has reached outside of its industry and into the design and technology realm with its latest appointment.  …

Appointment
Novartis image

FDA unconvinced on Novartis heart drug

March 26, 2014
Research and Development, Sales and Marketing FDA, Novartis, ahf, heart, serelaxin

The prospects of Novartis’ latest heart drug being approved in the US anytime soon appear to have been scuppered by …

News
Janssen image

Janssen psoriasis drug beats placebo

March 25, 2014
Research and Development, Sales and Marketing Janssen, dermatology, guselkumab

News
sanofi

Final no for Sanofi’s Zaltrap

March 25, 2014
Medical Communications, Sales and Marketing NICE, Sanofi, Zaltrap, colorectal cancer

News
elizabeth_kuiper_efpia

EFPIA hires director of European affairs

March 25, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA, kuiper

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has appointed Elizabeth Kuiper to be the director of its European …

Appointment

Parexel expands international operation

March 25, 2014
Manufacturing and Production, Sales and Marketing Parexel, Singapore, manufacturing

Biopharma services provider Parexel International Corporation is beefing up its global capacity and adding more secondary packaging and labelling services …

News

Xolair gets FDA approval for skin condition

March 24, 2014
Research and Development, Sales and Marketing FDA, Novartis, Roche, Sanofi, Xolair, chronic hives, csu

 An asthma drug developed by Roche subsidiary Genentech and Novartis has been granted an additional indication to treat chronic hives …

News

CHMP recommends Jardiance

March 24, 2014
Research and Development, Sales and Marketing Boehringer, CHMP, EU, diabetes, jardiance, lilly

Boehringer Ingelheim and Eli Lilly’s type 2 diabetes treatment Jardiance is among nine medicines which the Committee for Medicinal Products …

News
MSD image

Endocyte lung cancer drug shows promise

March 24, 2014
Research and Development, Sales and Marketing Endocyte, MSD, NSCLC, lung cancer, vintafolide

Endocyte and partner MSD have released positive mid-stage trial results for their investigational lung cancer drug vintafolide. The treatment met …

News
xofigo_bayer

NICE says ‘no’ to Xofigo

March 24, 2014
Sales and Marketing Bayer, CDF, NHS, NICE, abiraterone, prostate, xofigo

NICE has dealt Bayer a severe blow by not approving prostate cancer drug Xofigo for use on the NHS in …

News
jenny_cowderoy

Former Google head to lead comms for M3


March 24, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cowderoy, doctors.net, google, m3

Healthcare information provider M3 has appointed the former head of healthcare at Google as its managing director of communications in …

Appointment
EU flag image

Data transparency debate: Europe decides its future

March 24, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, EU, Goldacre, NHS, alltrials, european, transparency

Transparency became a major issue in 2013 as various new pressure groups sprung up with the shared aim of forcing …

Feature
Velcade image

NICE approves Velcade

March 21, 2014
Sales and Marketing Janssen, NHS, NICE, Velcade, myeloma

NICE has recommended Janssen’s proteasome inhibitor Velcade as an induction treatment for some patients with newly-diagnosed multiple myeloma. The draft …

News
Supercomputer image

IBM supercomputer could hold key to brain cancer

March 21, 2014
Medical Communications, Sales and Marketing avastin, brain cancer, ibm, nygc, supercomputer

The New York Genome Center and IBM Watson have joined forces to accelerate a new era of genomic medicine, initially …

News
dave_piacquad

Amgen names senior VP of Business Development

March 21, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, David Piacquad

Amgen has confirmed the appointment of David Piacquad to the new position of senior vice president of its Business Development …

Appointment
EMA image

EMA launches speedy pilot

March 21, 2014
Sales and Marketing BIA, EMA, MHRA, NICE, early access, trials

The European Medicines Agency (EMA) has launched an initiative aimed at speeding up the drug approval process and wants help …

News
Cairns image

AstraZeneca banks on MasterCard for director

March 20, 2014
Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Johansson, ann cairns, british gas, mastercard

AstraZeneca is proposing to elect the president of International Markets for MasterCard to stand as a non-executive director on its …

News
Vodaphone image

AstraZeneca signs Vodafone contract

March 20, 2014
Medical Communications, Sales and Marketing AstraZeneca, cardiovascular, mhealth, vodaphone

AstraZeneca has signed up with phone operator Vodafone to provide mobile health (mHealth) services for patients suffering from cardiovascular issues. …

News
GSK image

GSK cancer vaccine fails again

March 20, 2014
Sales and Marketing Cancer, GSK, MAGE-A3 cancer immunotherapeutic, NSCLC, lung cancer, melanoma

GlaxoSmithKline’s MAGE-A3 cancer immunotherapeutic has delivered another late-stage blow to the firm but it still vows to continue trials.  The …

News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026